Video

ESC 2015: Anticoagulants in atrial fibrillation: Identifying high risk patients

Published: 05 Oct 2015

  • Views:

    Views Icon 125

  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

 

Alexander Niessner discusses 'Anticoagulants in atrial fibrillation: Identifying high risk patients' at the 2015 ESC congress in London.

Questions:


1. In atrial fibrillation patients who need treatment with NOACs, how do you identify patients at a high-risk of bleeding?
2. How do you reduce the risk?